Oakmark International Strategy adds Unilever, Sanofi in Q4, exits Novartis [Seeking Alpha]
Press Release: Sanofi completes the acquisition of Dynavax
Sanofi CEO: The enterprise AI shift will reshape pharma in 2026 [Fortune]
Press Release: Sanofi's rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia [Yahoo! Finance]
Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia